Drugdiscovery >> Clinical Trials >> News
4944
Views
Teplizumab effective in phase 2 - drugdiscovery.com
Teplizumab effective in phase 2 - drugdiscovery.com


Teplizumab is an experimental drug designed to block the advance of type 1 diabetes in its earliest stages. It showed success in phase II clinical trial in patients who still had moderately healthy insulin production but not in those more advanced.
Read More >>


Tags: Teplizumab,experimental drug, clinical trial, type 1 diabetes, insulin, immunotherapy - August 11, 2013
Related Articles
6127
Views
Sofosbuvir effective in Phase II clinical trial for  hepatitis C Sofosbuvir effective in Phase II clinical trial for hepatitis C
Gilead's experimental drug sofosbuvir in combination with ribavirin showed to be effective and safe interferon-free therapy for even some of the toughest hepatitis C cases. Read More >>

Tags: sofosbuvir, hepatitis C, interferon-free therapy, ribavirin, clinical trial, Gilead

5428
Views
Lampalizumab  effective in Phase II clinical trial for macular degeneration Lampalizumab effective in Phase II clinical trial for macular degeneration
Roche’s new drug for age-related macular degeneration, lampalizumab, showed effective in slowing the progression of AMD in patients with advanced disease, shrinking the area of geographic atrophy by Read More >>

Tags: macular degeneration, age related, AMD, lampalizumab, clinical trial, Roche, new treatnment

6948
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

2804
Views
Interferon-free hepatitis coctail of AbbVie enters Phase III Interferon-free hepatitis coctail of AbbVie enters Phase III
The new drug of AbbVie has entered clinical trial phase II. It cures hepatitis C, and provides a ribavirin-free, all-oral treatment without interferon. Read More >>

Tags: interferon, hepatitis C, clinical trial, Phase III

3334
Views
Phase-III trial of new sarcoma drug Phase-III trial of new sarcoma drug
620 patients were enrolled to the Phase-III trial of TH-302. The trial is led by Threshold Pharmaceuticals. The new drug might open a new chapter in the history of advanced soft-tissue sarcoma. Read More >>

Tags: soft tissue sarcoma, phase-III trial, soft tissue

4179
Views
Pfizer’s  RA drug Xeljanz effective as a treatment for psoriasis Pfizer’s RA drug Xeljanz effective as a treatment for psoriasis
The results of the first two of five Phase 3 trials of Pfizer’s rheumatoid arthritis drug Xeljanz (tofacitinib) , a Janus kinase (JAK) inhibitor, indicate that it might be an effective treatment for Read More >>

Tags: Xeljanz,tofacitinib, plaque psoriasis, clinical trial

3762
Views
Novartis' omalizumab effective for severe urticaria Novartis' omalizumab effective for severe urticaria
The results of another late stage study of omalizumab (already on the market for asthma as Xolair) support earlier evidence that the drug is safe and effective as a treatment of chronic spontaneous ur Read More >>

Tags: omalizumab, Xolair, urticaria, hives, clinical trial, novartis

1445
Views
Amarantus has new drug in Phase II trial Amarantus has new drug in Phase II trial
Amarantus gains rights to Eltoprazine worldwide, excluding Asian territories. Amarantus expects to initiate a Phase 2b clinical trial for the treatment of Levadopa-Induced Dyskinesia associated with P Read More >>

Tags: amarantus, Levadopa, Dykinesia

3320
Views
Methotrexate effective in treating neuromyelitis optica? Methotrexate effective in treating neuromyelitis optica?
The results of a small study show that oral methotrexate therapy has potential for treating neuromyelitis optica, an autoimmune demyelinating disease affecting retinal nerves and the spinal cord. Read More >>

Tags: Methotrexate, neuromyelitis optica, treatment

4573
Views
Promising treatment for irritable bowel syndrome Promising treatment for irritable bowel syndrome
The drug Eluxadoline showed effective in Phase II clinical trial in the treatment of patients with diarrhea-predominant irritable bowel syndrome ( IBS-D). Phase III trials already started. Read More >>

Tags: Eluxadoline, irritable bowel syndrome, clinical trial, effective treatment

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013